DNP
Overvalued by 115.1% based on the discounted cash flow analysis.
Market cap | $3.56 Billion |
---|---|
Enterprise Value | $3.54 Billion |
Dividend Yield | $0.78 (8.09968847352025%) |
Earnings per Share | $2.28 |
Beta | 0.31 |
Outstanding Shares | 372,950,257 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 4.26 |
---|---|
PEG | 19.92 |
Price to Sales | 9.63 |
Price to Book Ratio | 1.2 |
Enterprise Value to Revenue | 7.26 |
Enterprise Value to EBIT | 224.26 |
Enterprise Value to Net Income | -29 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data